Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Express Scripts
Harvard Business School
Boehringer Ingelheim

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

ADCETRIS Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ADCETRIS
Patents:34
Applicants:1
BLAs:2
Suppliers: see list1
Pharmacology for ADCETRIS
Ingredient-typeImmunoconjugates
Mechanism of ActionCD30-directed Antibody Interactions
Physiological EffectMicrotubule Inhibition

US Patents for ADCETRIS

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing BRACCO IMAGING S.P.A. (Milan, IT) 2032-03-05 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing ADIENNE PHARMA & BIOTECH SA (Lugano, CH) 2037-05-31 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing The Johns Hopkins University (Baltimore, MD) 2030-05-26 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2032-11-14 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) 2034-12-23 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing University of Louisville Research Foundation, Inc. (Louisville, KY) 2033-02-08 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   See Pricing Massachusetts Institute of Technology (Cambridge, MA) 2032-05-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
AstraZeneca
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.